TRF1 and TRF2: pioneering targets in telomere-based cancer therapy - Publication - Bridge of Knowledge

Your account

login

Search

TRF1 and TRF2: pioneering targets in telomere-based cancer therapy

Abstract

This article presents an in-depth exploration of the roles of Telomere Repeat-binding Factors 1 and 2 (TRF1 and TRF2), and the shelterin complex, in the context of cancer biology. It emphasizes their emerging significance as potential biomarkers and targets for therapeutic intervention. Central to the shelterin complex, TRF1 and TRF2 are crucial in maintaining telomere integrity and genomic stability, their dysregulation often being a hallmark of cancerous cells. The article delves into the diagnostic and prognostic capabilities of TRF1 and TRF2 across various cancer types, highlighting their sensitivity and specificity. Furthermore, it reviews current strides in drug discovery targeting the shelterin complex, detailing specific compounds and their modes of action. The review candidly addresses the challenges in developing therapies aimed at the shelterin complex, including drug resistance, off-target effects, and issues in drug delivery. By synthesizing recent research findings, the article sheds light on the intricate relationship between telomere biology and cancer development. It underscores the urgency for continued research to navigate the existing challenges and fully leverage the therapeutic potential of TRF1, TRF2, and the shelterin complex in the realm of cancer treatment.

Citations

  • 0

    CrossRef

  • 0

    Web of Science

  • 0

    Scopus

Authors (5)

Cite as

Full text

full text is not available in portal

Keywords

Details

Category:
Articles
Type:
artykuły w czasopismach
Published in:
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY no. 150,
ISSN: 0171-5216
Language:
English
Publication year:
2024
Bibliographic description:
Kallingal A., Krzemieniecki R., Maciejewska N., Brankiewicz-Kopcinska W., Bagiński M.: TRF1 and TRF2: pioneering targets in telomere-based cancer therapy// JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY -,iss. 7 (2024),
DOI:
Digital Object Identifier (open in new tab) 10.1007/s00432-024-05867-3
Sources of funding:
  • Free publication
Verified by:
Gdańsk University of Technology

seen 14 times

Recommended for you

Evaluation and cellular responses of modulators of TRF1/TRF2 protein’s function as potential anticancer drugs interfering with telomeric shelterin’s function

2023

Molecular Recognition in Complexes of TRF Proteins with Telomeric DNA

2014

Modified Peptide Molecules As Potential Modulators of Shelterin Protein Functions; TRF1

2023

Molecular basis and quantitative assessment of TRF1 and TRF2 protein interactions with TIN2 and Apollo peptides

2017
Meta Tags